Low 25-Hydroxyvitamin D Levels and Cognitive Impairment in Hemodialysis Patients
Autor: | Mark J. Sarnak, Daniel E. Weiner, Kristina V. Lou, Tammy Scott, Hocine Tighiouart, David A. Drew, Kamran Shaffi |
---|---|
Rok vydání: | 2013 |
Předmět: |
Male
medicine.medical_specialty Epidemiology Cross-sectional study medicine.medical_treatment Neuropsychological Tests Critical Care and Intensive Care Medicine vitamin D deficiency Executive Function Cognition Memory Risk Factors Renal Dialysis Internal medicine Linear regression Prevalence Vitamin D and neurology medicine Humans Vitamin D Dialysis Aged Aged 80 and over Principal Component Analysis Transplantation business.industry Confounding Original Articles Middle Aged Vitamin D Deficiency medicine.disease Confidence interval Cross-Sectional Studies Treatment Outcome Nephrology Multivariate Analysis Linear Models Physical therapy Female Hemodialysis Cognition Disorders business Biomarkers Boston |
Zdroj: | Clinical Journal of the American Society of Nephrology. 8:979-986 |
ISSN: | 1555-9041 1065-1012 |
Popis: | Summary Background and objectives 25-hydroxyvitamin D (25[OH]D) deficiency and cognitive impairment are both prevalent inhemodialysis patients in theUnited States. This study tested thehypothesis that 25(OH)D deficiency may be associated with cognitive impairment because of its vasculoprotective, neuroprotective, and immunemodulatory properties. Design, setting, participants, & measurements This cross-sectional analysis involved 255 patients enrolled in the Dialysis and Cognition Study between 2004 and 2012. In linear regression models, 25(OH)D was the exposure variable; it was used first as a continuous variable and then stratified as deficient (,12 ng/ml), insufficient (12 to ,20 ng/ml), and sufficient ($20 ng/ml). Principal component analysis was used to obtain the memory and the executive function domains from the individual neurocognitive tests. Scores on individual tests as well as on the memory and executive function domains were the outcome variables. Multivariable models were adjusted for age, sex, race, education, and other potential confounding variables. Results Mean serum 25(OH)D 6 SD was 17.267.4 ng/ml, with 14%, 55%, and 31% of patients in the deficient, insufficient, and sufficient groups, respectively. Patients in the deficient group were more likely to be women, African American, and diabetic and to have longer dialysis vintage. Higher 25(OH)D levels were independently associated with better performance on several tests of executive function (mean difference on component executive score, 0.16 [95% confidence interval, 0.04–0.28; P=0.01] for each SD higher 25[OH]D). No association was seen with tests assessing memory. Conclusions 25(OH)D deficiency in hemodialysis patients is associated with worse cognitive function, particularly in domains that assess executive function. Clin J Am Soc Nephrol 8: ccc–ccc, 2013. doi: 10.2215/CJN.10651012 |
Databáze: | OpenAIRE |
Externí odkaz: |